UDG Healthcare appoints Jez Moulding as COO
UDG Healthcare has appointed Jez Moulding as chief operating officer of the company and executive vice president of the commercialisation division, Ashfield, with effect from 2 May.
Food & Drug Retailers
3,956.27
16:59 26/04/24
FTSE 250
19,824.16
16:59 26/04/24
FTSE 350
4,470.09
16:59 26/04/24
FTSE All-Share
4,423.59
17:14 26/04/24
UDG Healthcare Public Limited Company (CDI)
1,079.00p
16:34 13/08/21
Moulding will oversee the Ashfield division and will also have responsibility for IT, quality, compliance, strategy and communications as part of his role as COO of the healthcare firm.
He spent 18 years at French drugmaker Sanofi, holding numerous senior leadership positions and his most recent role was as senior vice president and North America region head for diabetes and cardiovascular.
Before Sanofi he worked at Astra Pharmaceuticals and Winchester Pharmaceuticals.
Chief executive Brendan McAtamney said: "He has extensive leadership experience in the pharmaceutical sector within our key global markets. His most recent experience leading the Sanofi North American business will be extremely valuable to us as we continue to develop our Ashfield US business and expand the group internationally."
Moulding added: "Ashfield has grown over many years and is a market leader in commercialisation services to global pharmaceutical clients. I look forward to building on this strong platform and driving further international expansion across the group."